Hot Stocks: Brokerage view on Tata Consumer, Varun Beverages and Mankind Pharma

[hfe_template id='11223'] [ad_1]
Brokerage firm Motilal Oswal initiated coverage on Mankind Pharma, Jefferies has a buy rating on Nykaa and Morgan Stanley recommended an overweight stance on Tata Consumer and Varun Beverages.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:

Motilal Oswal on Mankind Pharma: Buy| Target Rs 2650

Motilal Oswal initiated coverage on Mankind Pharma with a buy rating and a target of Rs 2,650. The company is working on multiple levers to boost growth over the next three to five years.

The company is increasing the scope of business in chronic therapies. It is enhancing its presence in metro/Tier-l cities.

The brokerage firm expects a 16% earnings CAGR for Mankind over FY24-27.

Jefferies on NYKAA: Buy| Target Rs 220

Jefferies maintained a buy rating on NYKAA with a target price of Rs 220. The beauty and personal care segment (BPC) offers significant growth headroom.An increase in user awareness should drive category growth. Fashion plays in a niche (premium) market.The global investment bank sees a clear need among customers who are value-conscious and not just discount-seeking.

BPC margins should be range-bound in the short term as growth is a priority.

Morgan Stanley on Tata Consumer: Overweight| Target Rs 1,288
Morgan Stanley maintained an overweight rating on Tata Consumer with a target price of Rs 1288.

The management is focused on growing the business and improving margins and return ratios for the existing business.

The core tea and salt business will target 5% volume growth and 7-8% value growth over the medium term.

The company will continue to evaluate inorganic opportunities. Nourishco, Sampann, Soulful, Capital Foods, and Organic India will grow at 30%.

EBITDA margins are expected to improve by 75-125bps annually.

Morgan Stanley on Varun Beverages: Overweight| Target Rs 1,701
Morgan Stanley maintained an overweight rating on Varun Beverages with a target of Rs 1701. The near-term demand benefits from heatwaves.

The medium-term focus is on thriving volume growth and maintaining margins. The company sees the opportunity to scale the food business in Africa. There is no further equity raise planned currently.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

[ad_2] Source link https://mrgaga.in/hot-stocks-brokerage-view-on-tata-consumer-varun-beverages-and-mankind-pharma/?feed_id=40603

Comments

Post a Comment

Popular posts from this blog

India VIX jumps 100% in one month. Could fear levels take Nifty further down?

Image
[hfe_template id='11223'] [ad_1] Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
Read more

Can Sensex, Nifty snap 2-day fall on Monday? 7 factors that could decide market mood this week

Image
[hfe_template id='11223'] [ad_1] Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
Read more

Waaree Energies shares in focus after Q4 profit rises 34% to Rs 619 crore, revenue up 36%

Image
[hfe_template id='11223'] [ad_1] Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
Read more